A high-res mi­cro­scope the size of a toast­er? A mi­croscopy start­up earns big-name VC back­ers

4 years ago
Financing

Re­call re­port: Miss­ing la­bel, mi­cro­bial con­t­a­m­i­na­tion leads to re­call of two batch­es of two drugs

4 years ago
Manufacturing

Man­u­fac­tur­ing woes con­tin­ue for Au­robindo af­ter FDA's warn­ing let­ter

4 years ago
Manufacturing

Mer­ck com­mer­cial chief Frank Clyburn de­parts for CEO role at DuPont co-owned ad­di­tives com­pa­ny

4 years ago
Pharma
Marketing

Covid-19 man­u­fac­tur­ing roundup: New pro­duc­tion site opens in Africa; Sen­a­tor calls for test prices to be slashed

4 years ago
Manufacturing

Johns Hop­kins and lo­cal biotech team up for new man­u­fac­tur­ing site; New oral drug plat­form to help ac­cel­er­ate R&D ...

4 years ago
Manufacturing

'Al­tos was re­al­ly a once-in-a-life­time op­por­tu­ni­ty': Hal Bar­ron re­flects on his big move

4 years ago
Bioregnum
Cell/Gene Tx

Covid-19 roundup: Gener­ic Mer­ck pill to be made for low­er-in­come coun­tries; Gavi says it needs a $5B boost — ...

4 years ago
Coronavirus

Eu­ro­pean Par­lia­ment signs off on strength­en­ing drug reg­u­la­tor's abil­i­ty to tack­le short­ages

4 years ago
Pharma
FDA+

Zymeworks re­places half its C-suite, aims to lay off 25% of to­tal work­force as new CEO takes over

4 years ago
People
R&D

Faced with in­tense in­vestor back­lash, Unilever now says $68B is its fi­nal of­fer for GSK con­sumer health­care busi­ness

4 years ago
Deals

Fol­low­ing CRL, Re­vance says it's clear on in­struc­tions for re­sub­mit­ting BLA

4 years ago
Manufacturing

Next-gen CAR-T play­er steps on the gas with a $111M boost and a pos­i­tive glimpse at ear­ly da­ta

4 years ago
Financing

Or­biMed takes point on a new biotech launch, but al­most every­thing re­mains se­cret for now

4 years ago
Financing
Startups

FDA+ roundup: FDA's neu­ro­science deputy de­parts amid on­go­ing Aduhelm in­ves­ti­ga­tions; Califf on the ropes?

4 years ago
FDA+

Chi­nese biotech teams with Lil­ly on car­diometa­bol­ic dis­eases; Sen­ate fi­nance chair goes af­ter BMS

4 years ago
News Briefing

Gilead says a net­work of sup­pli­ers and dis­trib­u­tors sold tens of thou­sands of fake ver­sions of its HIV meds

4 years ago
Pharma
FDA+

A Tony Coles Parkin­son's biotech, Yu­man­i­ty, con­tin­ues its back­slide as lead pro­gram earns a par­tial hold

4 years ago
FDA+

A George Church spin­out fight­ing the vi­ral vec­tor bot­tle­neck in cell and gene ther­a­py lands $55M

4 years ago
Financing
Manufacturing

Sec­ondary patents prove to be key in biosim­i­lar block­ing strate­gies, re­searchers find

4 years ago
Pharma

Al­most three years af­ter whiff­ing in a con­fir­ma­to­ry study, Mer­ck touts new da­ta for Keytru­da in HCC

4 years ago
FDA+

As­traZeneca rolls out 'un­prece­dent­ed' 3-year sur­vival da­ta for PD-L1/CT­LA4 com­bo in liv­er can­cer

4 years ago
R&D
Pharma

An un­ortho­dox pro­pos­al for Bio­gen's Medicare-man­dat­ed Aduhelm tri­al

4 years ago
R&D
Pharma

A new start­up wants to take an­ti­sense and siR­NA one step fur­ther, and build more po­tent drugs than Io­n­is and Al­ny­lam

4 years ago
Financing
Startups
First page Previous page 596597598599600601602 Next page Last page
A service from the Financial Times